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Introduction and Aims:Which creatinine-based GFR equation should preferentially
be used in the context of drug dosing is highly debated. While most Nephrology
guidelines recommend the use of the CKD-EPI equation, other specialists such as
geriatricians keep on favoring the use of the Cockcroft-Gault equation (C-G). Along
with the fact that dosing recommendations were most often initially done based on
C-G, the main justification is that this equation usually provides lower value of GFR as
compared to the CKD-EPI equation, and thus minimizes the risk of overdosing.
Herein, we wanted to verify whether this assertion was systematically true regardless of
demographic characteristics.
Methods:We developed a software program that explores, for different age strata and
gender, more than 500 combinations of weight and serum creatinine values. For each
combination, GFR was estimated by both CKD-EPI and C-G and the difference
(CKD-EPI - C-G) was calculated. We considered a difference in eGFR between -10 ml/
min and + 10 ml/min as a good agreement between CKD-EPI and C-G. Alternatively,
a difference below -10 ml/min and over +10 ml/min was considered as, respectively, a
significant higher and lower GFR estimation given by G-C as compared to CKD-EPI.
Results: Overall, levels of agreement were significantly improved for the highest strata
of ages with 36% and 62% of concordant GFR values for 40 and 80 years of age,
respectively (p<0.01). For strata of ages above 70 years, C-G systematically gave lower
GFR value for a weight below 60 kg and for a serum creatinine in the range of normal
or near normal values. For weights above 90 kg, C-G-based values were never lower
than CKD-EPI irrespective of the serum creatinine value. For strata of ages below 55
years, C-G provided significantly lower value of GFR in only less than 10% of the
simulations.
Conclusions: Our data challenge the notion that C-G systematically gives lower value
of GFR as compared to CKD-EPI. Age, weight and serum creatinine value are critical
factors influencing the agreement between C-G and CKD-EPI. The typical situation in
which C-G results in lower GFR estimates is a patient of 70 years old or more who
tends to be underweight and with a low/normal serum creatinine value. Our data do
not support the notion that disagreement between C-G and CKD-EPI should favor the
use of C-G for preventing drug overdosing.
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